HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Chalid Assaf Selected Research
Chalid Assaf Research Topics
Disease
25
Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
02/2024 - 01/2006
15
Neoplasms (Cancer)
02/2024 - 02/2004
14
Mycosis Fungoides
11/2023 - 07/2002
12
Lymphoma (Lymphomas)
01/2022 - 07/2002
3
Melanoma (Melanoma, Malignant)
04/2022 - 06/2006
3
T-Cell Lymphoma (Lymphoma, T Cell)
01/2021 - 04/2007
3
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2021 - 04/2009
2
Contact Dermatitis (Eczema, Contact)
01/2022 - 01/2022
2
Neoplasm Metastasis (Metastasis)
11/2016 - 04/2015
2
Disease Progression
01/2013 - 09/2007
2
B-Cell Lymphoma (Lymphoma, B Cell)
06/2010 - 09/2008
2
Necrosis
05/2008 - 06/2006
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2024
1
Basal Cell Carcinoma (Rodent Ulcer)
03/2024
1
Second Primary Neoplasms (Neoplasms, Second)
03/2024
1
Sarcoma (Soft Tissue Sarcoma)
03/2024
1
Diabetes Mellitus
03/2024
1
Skin Neoplasms (Skin Cancer)
03/2024
1
Arthritis (Polyarthritis)
02/2024
1
Graft vs Host Disease (Graft-Versus-Host Disease)
02/2024
1
Exanthema (Rash)
12/2023
1
Anemia
12/2023
1
Lymphopenia (Lymphocytopenia)
12/2023
1
Dermatitis
07/2022
1
Infections
01/2022
1
Cytokine Release Syndrome
10/2021
1
Vasculitis (Vasculitides)
09/2021
1
Sezary Syndrome (Sezary Erythroderma)
01/2020
1
Pain (Aches)
01/2019
1
Acute Promyelocytic Leukemia
01/2016
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2013
1
Cardiotoxicity
04/2013
1
Sepsis (Septicemia)
11/2012
1
Bullous Pemphigoid (Pemphigoid)
07/2012
1
Pemphigus (Pemphigus Vulgaris)
07/2012
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
06/2010
Drug/Important Bio-Agent (IBA)
4
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
07/2014 - 07/2002
4
Ligands
IBA
03/2010 - 06/2006
3
Mechlorethamine (Nitrogen Mustard)
FDA Link
07/2022 - 01/2022
3
Bexarotene (LGD1069)
FDA Link
01/2013 - 05/2008
2
Bendamustine Hydrochloride
FDA Link
01/2023 - 10/2020
2
Dimethyl Fumarate
IBA
01/2023 - 11/2016
2
pembrolizumab
IBA
04/2022 - 10/2021
2
1,2-cyclohexanediamine (dach)
IBA
01/2022 - 01/2022
2
Histone Deacetylase Inhibitors
IBA
08/2012 - 06/2009
2
Retinoid X Receptors (Retinoid X Receptor)
IBA
08/2012 - 05/2008
2
Histone Deacetylases (Histone Deacetylase)
IBA
08/2012 - 06/2009
2
Vorinostat
FDA Link
08/2012 - 05/2008
2
Antigens
IBA
07/2012 - 05/2008
2
denileukin diftitox (Ontak)
FDA Link
04/2010 - 01/2008
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
03/2010 - 03/2009
2
Death Domain Receptors
IBA
03/2010 - 10/2007
2
zanolimumab
IBA
12/2008 - 04/2007
1
Hydrochlorothiazide (Esidrix)
FDA Link
Generic
03/2024
1
Janus Kinase Inhibitors
IBA
02/2024
1
mogamulizumab
IBA
12/2023
1
Brentuximab Vedotin
IBA
01/2023
1
Ointments (Pastes)
IBA
07/2022
1
Biomarkers (Surrogate Marker)
IBA
04/2022
1
Gemcitabine
FDA Link
01/2022
1
Indicators and Reagents (Reagents)
IBA
01/2022
1
binimetinib
IBA
10/2021
1
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
10/2021
1
Transferases
IBA
10/2021
1
Creatine Kinase (Creatine Phosphokinase)
IBA
10/2021
1
encorafenib
IBA
10/2021
1
Immunoglobulins (Immunoglobulin)
IBA
09/2021
1
Anaplastic Lymphoma Kinase
IBA
01/2021
1
indirubin
IBA
03/2019
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
03/2019
1
Calcitonin Gene-Related Peptide
IBA
01/2019
1
Glucocorticoids
IBA
01/2019
1
Mineralocorticoids
IBA
01/2019
1
Protein Isoforms (Isoforms)
IBA
11/2016
1
Messenger RNA (mRNA)
IBA
11/2016
1
Arsenic Trioxide (Trisenox)
FDA Link
01/2016
1
Acids
IBA
01/2016
1
Retinoids
IBA
01/2016
1
Aurora Kinase A
IBA
09/2015
1
Doxorubicin (Adriamycin)
FDA Link
Generic
04/2013
1
liposomal doxorubicin (Doxil)
FDA Link
04/2013
1
1-dodecylpyridoxal (PLD)
IBA
04/2013
1
Panobinostat
IBA
01/2013
1
Anti-Bacterial Agents (Antibiotics)
IBA
11/2012
1
Retinoic Acid Receptors (Retinoic Acid Receptor)
IBA
08/2012
1
Autoantibodies
IBA
07/2012
1
Paraffin
IBA
06/2010
1
Interferon-gamma (Interferon, gamma)
IBA
06/2010
1
Recombinant Fusion Proteins
IBA
04/2010
1
Interleukin-2 (IL2)
IBA
04/2010
Therapy/Procedure
19
Therapeutics
12/2023 - 02/2004
2
Drug Therapy (Chemotherapy)
01/2022 - 04/2015
1
Stem Cell Transplantation
02/2024
1
Photopheresis
12/2023
1
Breast Implants (Breast Implant)
01/2021
1
Investigational Therapies (Experimental Therapy)
03/2019
1
Treatment Delay
11/2016
1
Radiotherapy
04/2015
1
Combination Drug Therapy (Combination Chemotherapy)
04/2013
1
Immunotherapy
06/2010